ArticleFrontiers in immunology2025

Isorhamnetin attenuates renal interstitial fibrosis by targeting TWEAK/Fn14-mediated epithelial-mesenchymal transition.

Yaping Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.